Internal Medicine, Interventional Cardiology · Sarasota, FL
NPI
1437388006
Since 2009
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
965 S Beneva Rd
Sarasota, FL, 34232
Phone (941) 366-1888
Groups this clinician bills Medicare through
Medicare paid, 2024
$774K
9,010 services
Medicare patients, 2024
3,085
Average age 77
Drug cost, 2024
$1.3M
5,008 prescriptions
Company payments, 2025
$536
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven J Czak was code 93010 (electrocardiogram), 1,665 times for 1,225 patients. In total Steven J Czak billed 9,010 services in 99 codes, and Medicare paid $774K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,665 | 1,225 | $6.52 | $11K |
| 99214 Office E&M - Established | Office | 1,335 | 982 | $91.16 | $122K |
| 93000 Electrocardiogram | Office | 708 | 654 | $10.52 | $7,450 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 544 | 135 | $5.53 | $3,010 |
| 93306 Echocardiography (TTE/TEE) | Office | 459 | 444 | $132.23 | $61K |
| 93306 Echocardiography (TTE/TEE) | Facility | 337 | 333 | $49.37 | $17K |
| 93298 External Electrocardiographic Monitoring | Office | 312 | 46 | $68.69 | $21K |
| 99223 Hospital E&M - Initial | Facility | 272 | 250 | $132.57 | $36K |
| 99215 Office E&M - Established | Office | 244 | 178 | $131.72 | $32K |
| 93015 Electrocardiogram | Office | 232 | 230 | $49.35 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 231 | 133 | $61.34 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 230 | 132 | $92.25 | $21K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 223 | 111 | $312.86 | $70K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 184 | 92 | $96.46 | $18K |
| 36415 Venipuncture Blood Collection | Office | 139 | 119 | $8.65 | $1,202 |
By year: 2022 $509K for 6,053 services; 2023 $685K for 9,095 services; 2024 $774K for 9,010 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 139 | 119 | $8.65 | $1,202 |
| 80053 Clinical Chemistry | 86 | 83 | $10.45 | $899 |
| 80061 Clinical Chemistry | 78 | 74 | $13.12 | $1,023 |
| 82565 Clinical Chemistry | 30 | 30 | $5.02 | $151 |
| 85025 Blood Count | 26 | 26 | $7.72 | $201 |
| 84443 Clinical Chemistry | 19 | 19 | $16.46 | $313 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven J Czak prescribed most often to Medicare patients was Atorvastatin Calcium, with 958 prescriptions and refills. In total Steven J Czak wrote 5,008 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 958 | 2,811 | 327 | $7,425 |
| Eliquis Apixaban | 488 | 1,090 | 147 | $617K |
| Rosuvastatin Calcium Generic | 417 | 1,240 | 148 | $7,227 |
| Metoprolol Succinate Generic | 368 | 1,053 | 149 | $3,831 |
| Amlodipine Besylate Generic | 254 | 711 | 88 | $1,299 |
| Metoprolol Tartrate Generic | 238 | 649 | 90 | $1,935 |
| Losartan Potassium Generic | 213 | 622 | 95 | $2,123 |
| Lisinopril Generic | 199 | 577 | 71 | $1,240 |
| Xarelto Rivaroxaban | 161 | 395 | 47 | $215K |
| Clopidogrel Clopidogrel Bisulfate | 117 | 345 | 54 | $1,072 |
| Potassium Chloride Generic | 96 | 214 | 44 | $1,984 |
| Carvedilol Generic | 90 | 272 | 33 | $827 |
| Furosemide Generic | 88 | 198 | 44 | $263 |
| Valsartan Generic | 82 | 245 | 26 | $2,113 |
| Simvastatin Generic | 73 | 221 | 22 | $514 |
Brand drugs: 890 claims; generic drugs: 4,118 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven J Czak $536 ($536 in general payments such as food, travel and fees) from 7 companies. The largest payer was Novartis Pharmaceuticals Corporation with $174.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.